Terumo (OTCMKTS:TRUMY) Posts Earnings Results, Beats Expectations By $0.13 EPS

Terumo (OTCMKTS:TRUMY) issued its earnings results on Friday. The company reported $0.30 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.13, Zacks reports. Terumo had a net margin of 12.09% and a return on equity of 9.17%.

Terumo Stock Up 9.0%

TRUMY stock traded up $1.31 during trading on Friday, hitting $15.85. 56,969 shares of the company’s stock were exchanged, compared to its average volume of 287,936. The business has a 50-day moving average price of $13.98 and a two-hundred day moving average price of $13.54. The stock has a market capitalization of $23.38 billion, a price-to-earnings ratio of 25.98 and a beta of 0.68. Terumo has a 52-week low of $12.08 and a 52-week high of $19.60. The company has a current ratio of 1.59, a quick ratio of 0.97 and a debt-to-equity ratio of 0.06.

Wall Street Analyst Weigh In

Several research firms have commented on TRUMY. Nomura upgraded shares of Terumo from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 30th. Zacks Research upgraded shares of Terumo to a “hold” rating in a research note on Thursday, April 9th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Buy”.

About Terumo

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.